Welcome to our dedicated page for Q2 Holdings SEC filings (Ticker: QTWO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Q2 Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Q2 Holdings's regulatory disclosures and financial reporting.
John Breeden reported sales of company common stock under Rule 144. The filing lists two restricted/common share sales: 8,521 shares on 03/03/2026 and 33,445 shares on 03/04/2026
QTWO disclosure: a Form 144 shows Common stock transactions routed through Morgan Stanley Smith Barney LLC on 03/05/2026. The filing lists 9,554 securities described as Restricted and Performance Stock Units with sale activity by Michael Kerr: 7,157 shares on 03/04/2026 and 1,550 shares on 03/03/2026.
QTWO affiliate filed a Form 144 reporting proposed and completed sales of company common stock in early March. The filing lists Restricted and Performance Stock Units to be sold totaling 20,948 units dated 03/02/2026, and two executed transactions by Kimberly Rutledge: 3,905 shares for $194,156.60 on 03/03/2026 and 19,924 shares for $991,219.00 on 03/04/2026.
Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman reported a mix of stock awards and sales. He acquired 23,556 and 21,746 shares of common stock at no cost from performance-based restricted stock units granted on March 2, 2023, after meeting vesting conditions tied to Adjusted EBITDA of Revenue and stock-price performance versus an industry index. To cover tax withholding on vested restricted stock units, he executed issuer-mandated open-market sales of 7,752 shares at $49.72 per share and 31,104 shares at $49.75 per share. Following these transactions, he directly holds 262,657 shares of Q2 Holdings common stock.
Form 144 filing reports insider sales by Kirk Coleman. The filing lists three restricted/common stock dispositions: 8,559 shares on 12/10/2025, 12,917 shares on 02/17/2026, and 7,752 shares on 03/03/2026. Each sale shows gross proceeds in the filing alongside the share counts.
QTWO filing reports an intended sale of 1,793 restricted stock units/performance stock units by Himagiri Mukkamala on 03/04/2026.
The filing also lists a prior sale of 3,024 common shares on 12/10/2025. The securities are listed as Common and the transaction is tied to issuer-held RSU/PSU awards.
Q2 Holdings, Inc. Chief Operating Officer Mukkamala Himagiri K reported an issuer-mandated sale of 1,793 shares of common stock to cover tax withholding tied to vesting of restricted stock units. The weighted average sale price was about $49.75 per share, leaving him with 94,253 shares of directly held common stock.
Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported a mix of stock awards and mandated sales. He received two grants of common stock totaling tens of thousands of shares at no cost upon vesting of performance-based restricted stock units tied to EBITDA and stock-price benchmarks. To cover tax withholding from these vestings, he sold 41,966 shares of common stock in open-market transactions at weighted-average prices around $49.7 per share. After these transactions, he directly owned 159,019 shares of Q2 Holdings common stock.
QTWO submitted a Form 144 notice reporting proposed sales of equity. The notice lists 33,445 Restricted Stock Units/Performance Stock Units to be sold and shows that 8,521 common shares were sold on 03/03/2026 for $423,681.63. The broker listed is Morgan Stanley at 1585 Broadway, New York, NY.
Q2 Holdings, Inc. General Counsel Michael S. Kerr reported multiple stock transactions in company common shares. He received grants or awards of 6,282 shares on March 2 and 5,799 shares on March 3, both at a price of $0.00 per share, reflecting vesting of performance-based restricted stock units tied to company metrics. He then executed issuer-mandated open-market sales of 1,550 shares at $49.72 on March 3 and 7,157 shares at a weighted average price of $49.75 on March 4 to cover tax withholding obligations upon vesting. After these transactions, he directly held 59,602 shares of Q2 Holdings common stock.